NYSE:MED Medifast (MED) Stock Price, News & Analysis $20.49 +0.96 (+4.92%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$19.55▼$20.6050-Day Range$18.43▼$26.0852-Week Range$17.86▼$109.52Volume281,451 shsAverage Volume471,154 shsMarket Capitalization$224.16 millionP/E Ratio3.30Dividend YieldN/APrice Target$49.75 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get Medifast alerts: Email Address Medifast MarketRank™ Stock AnalysisAnalyst RatingReduce1.50 Rating ScoreUpside/Downside142.8% Upside$49.75 Price TargetShort InterestBearish27.90% of Float Sold ShortDividend StrengthN/ASustainability-4.00Upright™ Environmental ScoreNews Sentiment0.02Based on 5 Articles This WeekInsider TradingN/AProj. Earnings Growth94.68%From $0.94 to $1.83 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.87 out of 5 starsConsumer Staples Sector52nd out of 136 stocksMiscellaneous Food Preparations & Kindred Products Industry2nd out of 4 stocks 2.8 Analyst's Opinion Consensus RatingMedifast has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no buy ratings, 1 hold rating, and 1 sell rating.Amount of Analyst CoverageMedifast has only been the subject of 1 research reports in the past 90 days.Read more about Medifast's stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted27.90% of the float of Medifast has been sold short.Short Interest Ratio / Days to CoverMedifast has a short interest ratio ("days to cover") of 5.1.Change versus previous monthShort interest in Medifast has recently increased by 0.68%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldMedifast does not currently pay a dividend.Dividend GrowthMedifast does not have a long track record of dividend growth. Previous Next 2.0 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreMedifast has received a -1.18% net impact score from Upright. The largest negative impact of Medifast in category "GHG emissions" seems to be driven mostly by its "Meal replacement soups", "Meal replacement bars", "Meal replacement drinks", and "Protein bars" products. See details.Environmental SustainabilityThe Environmental Impact score for Medifast is -4.00. Previous Next 2.2 News and Social Media Coverage News SentimentMedifast has a news sentiment score of 0.02. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.50 average news sentiment score of Consumer Staples companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Medifast this week, compared to 3 articles on an average week.Search InterestOnly 7 people have searched for MED on MarketBeat in the last 30 days. This is a decrease of -30% compared to the previous 30 days.MarketBeat Follows5 people have added Medifast to their MarketBeat watchlist in the last 30 days. This is an increase of 150% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Medifast insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.50% of the stock of Medifast is held by insiders.Percentage Held by Institutions95.51% of the stock of Medifast is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Medifast's insider trading history. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Medifast are expected to grow by 94.68% in the coming year, from $0.94 to $1.83 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Medifast is 3.30, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 140.95.Price to Earnings Ratio vs. SectorThe P/E ratio of Medifast is 3.30, which means that it is trading at a less expensive P/E ratio than the Consumer Staples sector average P/E ratio of about 21.64.Price to Book Value per Share RatioMedifast has a P/B Ratio of 1.11. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Medifast's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad American Hartford Gold GroupPrepare for a Recession Unlike Any OtherDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.GET THE FREE GUIDE About Medifast Stock (NYSE:MED)Medifast, Inc., through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.Read More MED Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MED Stock News HeadlinesJuly 23 at 6:58 AM | americanbankingnews.comMedifast (NYSE:MED) Given "Underperform" Rating at DA DavidsonJuly 22, 2024 | businesswire.comMedifast to Announce Financial Results for the Second Quarter Ended June 30, 2024July 26, 2024 | American Hartford Gold Group (Ad)Prepare for a Recession Unlike Any OtherDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.July 22, 2024 | investorplace.comTime to Unload: 3 Stocks in Deep Trouble to Sell NowJune 14, 2024 | investorplace.com3 Stocks to Sell as Ozempic Surges in PopularityJune 12, 2024 | investorplace.com7 Small-Cap Value Stocks Leaving the S&P 500 in the DustJune 7, 2024 | prnewswire.comKKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600May 24, 2024 | seekingalpha.comMedifast: Significant Undervaluation Even As Struggles PersistJuly 26, 2024 | American Hartford Gold Group (Ad)Prepare for a Recession Unlike Any OtherDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.May 22, 2024 | stockhouse.comINVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Medifast, Inc. and Encourages Investors to Contact the FirmMay 22, 2024 | finance.yahoo.comInvestors Could Be Concerned With Medifast's (NYSE:MED) Returns On CapitalMay 20, 2024 | investorplace.comInvest in the Underestimated: 7 Bargain Stocks Poised to Prove Wall Street WrongMay 20, 2024 | finance.yahoo.comMedifast Continues Business Transformation, Launching National Marketing Campaign Promoting its Holistic Offering for Customers Utilizing and Considering Weight Loss MedicationsMay 20, 2024 | businesswire.comMedifast Continues Business Transformation, Launching National Marketing Campaign Promoting its Holistic Offering for Customers Utilizing and Considering Weight Loss MedicationsMay 18, 2024 | sg.finance.yahoo.comMED Jun 2024 65.000 putMay 16, 2024 | bizjournals.comMedifast closes Maryland warehouse, lays off 62 workersMay 13, 2024 | investorplace.comPocket-Sized Powerhouses: 7 Small-Cap Value Stocks Ready to RoarMay 9, 2024 | finance.yahoo.comQ1 2024 LifeMD Inc Earnings CallSee More Headlines Receive MED Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medifast and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/29/2024Today7/26/2024Next Earnings (Confirmed)8/05/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorConsumer Staples Industry Miscellaneous food preparations & kindred products Sub-IndustryPersonal Products Current SymbolNYSE:MED CUSIP58470H10 CIK910329 Webwww.medifast1.com Phone(410) 581-8042Fax410-581-8070Employees634Year FoundedN/APrice Target and Rating Average Stock Price Target$49.75 High Stock Price Target$82.00 Low Stock Price Target$17.50 Potential Upside/Downside+147.8%Consensus RatingReduce Rating Score (0-4)1.50 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)$6.20 Trailing P/E Ratio3.24 Forward P/E Ratio21.36 P/E GrowthN/ANet Income$99.42 million Net Margins7.55% Pretax Margin9.70% Return on Equity36.64% Return on Assets23.16% Debt Debt-to-Equity RatioN/A Current Ratio2.84 Quick Ratio2.25 Sales & Book Value Annual Sales$1.07 billion Price / Sales0.20 Cash Flow$11.54 per share Price / Cash Flow1.74 Book Value$18.50 per share Price / Book1.09Miscellaneous Outstanding Shares10,940,000Free Float10,664,000Market Cap$219.68 million OptionableOptionable Beta1.15 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Daniel R. Chard (Age 59)Executive Chairman & CEO Comp: $1.94MMr. James P. Maloney CPA (Age 56)Chief Financial Officer Comp: $823.91kMr. Anthony E. Tyree (Age 59)Chief Business Operations Officer Comp: $655.86kMr. Jason L. Groves Esq. (Age 53)Executive VP, General Counsel & Corporate Secretary Comp: $669.51kMr. Nicholas M. Johnson (Age 44)Chief Field Operations Officer Comp: $696.4kMr. Jonathan Barrett MacKenzie (Age 52)VP of Finance & Chief Accounting Officer Mr. Steven ZenkerVice President of Investor RelationsMs. Claudia C. Greninger (Age 51)Chief Human Resources Officer More ExecutivesKey CompetitorsNu Skin EnterprisesNYSE:NUSNature's Sunshine ProductsNASDAQ:NATRVeruNASDAQ:VERUEstée Lauder CompaniesNYSE:ELInter ParfumsNASDAQ:IPARView All CompetitorsInsiders & InstitutionsBank of New York Mellon CorpSold 37,837 shares on 7/26/2024Ownership: 0.679%Allspring Global Investments Holdings LLCSold 37,837 shares on 7/26/2024Ownership: 0.046%Zweig DiMenna Associates LLCBought 112,400 shares on 7/24/2024Ownership: 1.027%Nisa Investment Advisors LLCSold 1,455 shares on 7/20/2024Ownership: 0.015%Values First Advisors Inc.Bought 43,663 shares on 7/19/2024Ownership: 0.596%View All Insider TransactionsView All Institutional Transactions MED Stock Analysis - Frequently Asked Questions How have MED shares performed this year? Medifast's stock was trading at $67.22 at the beginning of 2024. Since then, MED shares have decreased by 69.5% and is now trading at $20.49. View the best growth stocks for 2024 here. How were Medifast's earnings last quarter? Medifast, Inc. (NYSE:MED) released its earnings results on Monday, April, 29th. The specialty retailer reported $0.66 earnings per share for the quarter, missing analysts' consensus estimates of $0.78 by $0.12. The firm's revenue for the quarter was down 49.9% compared to the same quarter last year. What is Daniel Chard's approval rating as Medifast's CEO? 44 employees have rated Medifast Chief Executive Officer Daniel Chard on Glassdoor.com. Daniel Chard has an approval rating of 93% among the company's employees. This puts Daniel Chard in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. Who are Medifast's major shareholders? Top institutional investors of Medifast include Zweig DiMenna Associates LLC (1.03%), Bank of New York Mellon Corp (0.68%), Values First Advisors Inc. (0.60%) and Allspring Global Investments Holdings LLC (0.05%). Insiders that own company stock include Daniel R Chard, Kevin G Byrnes, Scott Schlackman, Andrea B Thomas, Jeffrey J Brown and Constance J Hallquist. View institutional ownership trends. How do I buy shares of Medifast? Shares of MED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Medifast own? Based on aggregate information from My MarketBeat watchlists, some other companies that Medifast investors own include NVIDIA (NVDA), Alibaba Group (BABA), AbbVie (ABBV), Home Depot (HD), Boeing (BA), Johnson & Johnson (JNJ) and Intel (INTC). This page (NYSE:MED) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medifast, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medifast With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MED Stock Alerts